Chromatography
Detecting Nitrosamine content in Pharmaceutical Drugs
Mar 10 2020
The news has recently been full of worldwide high-profile product recalls of various pharmaceutical drugs that have been found to contain nitrosamines. Nitrosamine are carcinogenic compounds so need to be monitored to ensure unsafe levels are not found in consumer products.
The Ellutia 800 Series TEA is the industry standard for nitrosamine detection thanks to is selectivity and sensitivity for Nitroso compounds. For testing of pharmaceutical drugs, The 800 Series TEA can be interfaced to a chemical stripping system that allows for rapid testing of ATNC (Apparent Total N-nitrosamine content). This quickly gives an accurate result for the total nitrosamine content of a sample showing both volatile and non-volatile components.
Any positive sample can then be further analysed by an 800 Series TEA interfaced to a GC where volatile nitrosamines such as NDMA (N-Nitrosodimethylamine) can be separated and quantified.
For further information on how the Ellutia 800 Series TEA can help with the detection of nitrosamines in pharmaceutical drugs please visit
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan